Pacific Edge posts $14.5m loss as it awaits US Medicare decisions

Pacific Edge posts $14.5m loss as it awaits US Medicare decisions
Pacific Edge chief executive Peter Meintjes says as each day passes, he feels more confident about a favourable decision from Novitas. (Image: Supplied)
John Anthony
Dunedin-headquartered cancer diagnostics company Pacific Edge has posted a $14.5 million after-tax loss for the six months to September 30.The NZX and ASX-listed company said it was awaiting outcomes of several events that had the potential to renew growth in Cxbladder, its urine-based genomic biomarker test for the detection and surveillance of bladder cancer. The events include:Novitas, the Medicare Administrative Contractor (MAC) with responsibility for Pacific Edge’s US lab, making a favourable policy decision on a Local Coverage...

More Markets

NZX sits out tech rally, trades flat
Markets Market Close

NZX sits out tech rally, trades flat

"We're not overly blessed with big tech names," Generate's Greg Smith said.

Gregor Thompson 23 Sep 2025
Kiwi sinks to 15-year low against euro
Economy

Kiwi sinks to 15-year low against euro

Kiwi may soften further against euro as traders price in cash rate expectations.

Andy Macdonald 23 Sep 2025
Contact to supply gas under all-of-government contract
Markets

Contact to supply gas under all-of-government contract

Contact Energy has signed an agreement with the Ministry of Business, Innovation and Employment to supply about 1.65 petajoules (PJ) of gas a year, starting from Oct 1.Under the new arrangement, Contact will supply seven years’ worth of gas to some 100 Government agencies and ins...

Staff reporters 23 Sep 2025
Seabed miner wants to list on the NZX
Primary Sector

Seabed miner wants to list on the NZX

The mining project has been one of the most hotly contested in NZ.

Ian Llewellyn 23 Sep 2025